Swiss All Share Index

Swiss All Share Index handeln
17.704,72 PKT -266,25 PKT -1,48 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
12.10.12 UBS outperform Credit Suisse Group
12.10.12 Novartis reduce Vontobel Research
12.10.12 Givaudan outperform Exane-BNP Paribas SA
12.10.12 Swiss Re buy Société Générale Group S.A. (SG)
12.10.12 Sulzer buy Sarasin Research
12.10.12 Novartis buy UBS AG
11.10.12 ABB (Asea Brown Boveri) outperform Exane-BNP Paribas SA
11.10.12 Novartis buy Deutsche Bank AG
11.10.12 Novartis buy UBS AG
11.10.12 Swisscom neutral Nomura
11.10.12 Temenos outperform Exane-BNP Paribas SA
11.10.12 Nestlé overweight Morgan Stanley
11.10.12 Kühne + Nagel International hold Vontobel Research
11.10.12 Avolta (ex Dufry) buy Vontobel Research
11.10.12 EMS-CHEMIE hold Vontobel Research
10.10.12 UBS overweight J.P. Morgan Cazenove
10.10.12 Swatch (I) outperform Credit Suisse Group
10.10.12 Nestlé neutral UBS AG
10.10.12 Richemont neutral Credit Suisse Group
10.10.12 Kühne + Nagel International underperform Cheuvreux SA
10.10.12 Sulzer outperform Cheuvreux SA
10.10.12 Sonova underperform Exane-BNP Paribas SA
10.10.12 Julius Bär buy Nomura
10.10.12 Sulzer buy UBS AG
10.10.12 Givaudan equal-weight Morgan Stanley
10.10.12 EMS-CHEMIE hold Vontobel Research
10.10.12 Avolta (ex Dufry) buy Vontobel Research
10.10.12 EMS-CHEMIE buy Sarasin Research
10.10.12 Avolta (ex Dufry) neutral Sarasin Research
10.10.12 ams-OSRAM buy Vontobel Research
10.10.12 Givaudan hold Vontobel Research
09.10.12 Nestlé buy Société Générale Group S.A. (SG)
09.10.12 Givaudan reduce Nomura
09.10.12 ABB (Asea Brown Boveri) underperform Cheuvreux SA
09.10.12 Kühne + Nagel International buy Nomura
09.10.12 Julius Bär buy Sarasin Research
09.10.12 Givaudan neutral Sarasin Research
09.10.12 Givaudan hold Vontobel Research
09.10.12 Holcim outperform Sanford C. Bernstein and Co., Inc.
08.10.12 Novartis halten Independent Research GmbH